Search results for "Plasma viscosity"

showing 10 items of 10 documents

Haemorheological components in the pre-geriatric and geriatric age range in a randomly selected Western Sicily population sample (Casteldaccia study)

1993

{Received 24.8.1992; accepted 7.12.1992} On a randomly selected western Sicily population sample (Casteldac­ cia Study: 600 subjects; 300 males and 300 females) of an age range from 40 to 79 years, were determined: Haematocrit (Htc) , blood vi­ scosity, plasma viscosity, filterability of whole blood and fibrinogen. Par­ ticipation was 97%, being 582 subjects (M = 287, F = 295). All the parameters measured showed a progressive increase with age and si­ gnificant differences were found between male and female subjects: Htc and blood viscosity were higher in male subjects (p < 0.01), while plasma viscosity, whole blood filterability and fibrinogen were higher in female subjects (p < 0.05). In …

medicine.medical_specialtyPopulation samplePhysiologybusiness.industryBlood viscosityHematologyFibrinogenGastroenterologyCoronary heart diseaseSurgeryPhysiology (medical)Internal medicinemedicineRisk factorCardiology and Cardiovascular MedicinebusinessPlasma viscosityWhole bloodmedicine.drugClinical Hemorheology and Microcirculation
researchProduct

Plasma Viscosity and NLR in Young Subjects with Myocardial Infarction: Evaluation at the Initial Stage and at 3 and 12 Months

2018

In the “Sicilian study on juvenile myocardial infarction,” we had evaluated plasma viscosity (PV) and neutrophil/lymphocyte ratio (NLR) in patients with acute myocardial infarction (AMI) at the age of ⩽45 years. Now, we examined the relationship between these 2 parameters in 120 subjects (109 men and 11 women) aged ⩽45 years with recent AMI. The patients were classified according to the number of cardiovascular risk factors, the electrocardiographic criteria (ST-segment elevation myocardial infarction [STEMI] or non-ST-segment elevation myocardial infarction [NSTEMI]), and the extent of coronary stenosis, evaluated with coronary angiography. On fasting venous blood, we measured PV at the sh…

lcsh:Diseases of the circulatory (Cardiovascular) systemmedicine.medical_specialtySettore MED/09 - Medicina Internabusiness.industryLymphocytefungimedicine.diseaseneutrophil lymphocyte ratiomedicine.anatomical_structurelcsh:RC666-701Internal medicinecardiovascular systemCardiologyMedicineplasma viscosityIn patientcardiovascular diseasesMyocardial infarctionjuvenile myocardial infarctionStage (cooking)Cardiology and Cardiovascular MedicinebusinessPlasma viscosityOriginal ResearchClinical Medicine Insights: Cardiology
researchProduct

Plasma viscosity pattern and erythrocyte aggregation in two patients with congenital afibrinogenemia

2020

: In this case report, we examine the behavior of plasma viscosity, explored at high and low shear rates, and erythrocyte aggregation in two patients with congenital afibrinogenemia, a clinical disorder firstly described in 1920 and that has an estimated incidence of 1 : 1-200 0000. The two hemorheological parameters examined by us showed a marked decrease in both patients, in one of whom erythrocyte aggregation was even undetectable. Keeping in mind that spontaneous thrombosis (venous and arterial) has been often described in congenital afibrinogenemia, it can be hypothesized that the decrease in plasma viscosity and erythrocyte aggregation might cause a reduction of the endothelial synthe…

AdultErythrocyte Aggregationmedicine.medical_specialty030204 cardiovascular system & hematologyErythrocyte aggregationNitric oxidePlasmaYoung Adult03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicinemedicineShear stressHumansPlasma viscositybusiness.industryPlasma viscosity afibrinogenemiaHematologyGeneral MedicineMiddle AgedAfibrinogenemiaBlood Viscositymedicine.diseaseCongenital afibrinogenemiaEndocrinologychemistryFemaleStress MechanicalbusinessSpontaneous thrombosis030215 immunology
researchProduct

Hemorheology in the metabolic syndrome.

2011

blood viscosity plasma viscosity insulin resistance
researchProduct

High Output Heart Failure in Multiple Myeloma: Pathogenetic Considerations.

2022

The high output heart failure is a clinical condition in which the systemic congestion is associated to a high output state, and it can be observed in a non-negligible percentage of hematological diseases, particularly in multiple myeloma, a condition in which the risk of adverse cardiovascular events may increase, with a worse prognosis for patients. For this reason, though an accurate literature search, we provided in this review a complete overview of different pathogenetic mechanisms responsible for high output heart failure in multiple myeloma. Indeed, this clinical finding is present in the 8% of multiple myeloma patients, and it may be caused by artero-venous shunts, enhanced angioge…

multiple myelomaangiogenesisCancer ResearchOncologyhyperammonemiahigh output heart failureNeoplasms. Tumors. Oncology. Including cancer and carcinogensangiogenesiglutamminolysiplasma viscosityglutamminolysisRC254-282artero-venous fistulaeCancers
researchProduct

Influence of lipids on blood and plasma viscosity.

2014

Amparo Vayaa,∗, Cristina Gimeneza, Rafael Alisb,c, Julian Muradoa and Oscar Fustera aHemorheology and Haemostasis Unit, Service of Clinical Pathology, La Fe University Hospital, Valencia, Spain bResearch Universitary Institute “Dr. Vina Giner”, Molecular and Mitochondrial Medicine, Catholic University of Valencia “San Vicente Martir”, Valencia, Spain cFaculty of Medicine, Catholic University of Valencia “San Vicente Martir”, Valencia, Spain

Malemedicine.medical_specialtybiologyPhysiologybusiness.industryHematologybiology.organism_classificationUniversity hospitalLipidsPhysiology (medical)Family medicineHemorheologymedicineHumansFemaleCardiology and Cardiovascular MedicinePlasma viscositybusinessValenciaClinical hemorheology and microcirculation
researchProduct

Hemorheological parameters in Monoclonal Gammopathy of Undetermined Significance (MGUS).

2018

There is scarcity of information about the hemorheological pattern in subjects with Monoclonal Gammopathy of Undetermined Significance (MGUS). This preliminary research is focused on the behaviour of whole-blood and plasma viscosity, haematocrit and erythrocyte deformability in the above clinical condition. We enrolled 21 MGUS subjects (10 women and 11 men; mean age 66.4 ± 11.6 years). In fasting venous blood we examined whole-blood and plasma viscosity at high and low shear rates, haematocrit, the ratios between whole-blood viscosity (at high and low shear rate) and haematocrit × 100, the ratio between plasma viscosity at low and high shear rate, and the erythrocyte deformability expressed…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaPhysiologyBlood viscosity030204 cardiovascular system & hematologyMonoclonal Gammopathy of Undetermined SignificanceSettore MED/15 - Malattie Del Sangue03 medical and health sciencesViscosity0302 clinical medicinehemic and lymphatic diseasesPhysiology (medical)Internal medicineErythrocyte DeformabilitymedicineErythrocyte deformabilityHumanscardiovascular diseasesPlasma viscosityParaproteinemia; blood viscosity; erythrocyte deformability; plasma viscosityAgedChemistryMean ageHematologyVenous bloodmedicine.diseaseBlood ViscosityShear rateParaproteinemiaEndocrinology030220 oncology & carcinogenesisplasma viscosityFemaleCardiology and Cardiovascular MedicineRheologyMonoclonal gammopathy of undetermined significanceClinical hemorheology and microcirculation
researchProduct

Red blood cell deformability in multiple myeloma1.

2018

The aim of this study was the evaluation of the erythrocyte deformability in multiple myeloma (MM). We enrolled 29 MM patients and we evaluated, on fasting venous blood, the erythrocyte deformability, expressed as elongation index, and examined using the diffractometric method. By comparing normal controls and MM patients, a significant decrease in erythrocyte deformability, especially at low shear stresses, was found. In this research paper we evaluated all the hypothesis for a possible explanation of the behaviour of red blood cell deformability in MM, even considering how the alteration of erythrocyte deformability worsens the microcirculatory flow in these patients in association with t…

Malemedicine.medical_specialtyPhysiology030204 cardiovascular system & hematologyMicrocirculation03 medical and health sciences0302 clinical medicinePhysiology (medical)Internal medicineErythrocyte DeformabilitymedicineErythrocyte deformabilityHumansPlasma viscosityMultiple myelomaAgedHematologyChemistryMicrocirculationHematologyVenous bloodmedicine.diseaseMicrocirculatory flowRed blood cellmedicine.anatomical_structureEndocrinology030220 oncology & carcinogenesisFemaleCardiology and Cardiovascular MedicineMultiple MyelomaClinical hemorheology and microcirculation
researchProduct

Erythrocyte deformability and hemorheological profile in multiple myeloma

2018

The hemorheological profile in multiple myeloma (MM) has been extensively studied. Our investigation regarded the behavior of whole-blood viscosity, plasma viscosity and erythrocyte deformability in MM. We enrolled 24 MM patients; 13 of them had been recently diagnosed and were at the initial stage of therapy, 6 were on consolidation/conservation therapy and 5 had achieved a complete remission. On fasting venous blood we evaluated whole-blood and plasma viscosity at high and low shear rates, haematocrit, the ratios between whole-blood viscosity (at high and low shear rate) and haematocrit×100, the ratio between plasma viscosity at low and high shear rate and the erythrocyte deformability ex…

MalePhysiology030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineErythrocyte DeformabilityPhysiology (medical)medicineHumansErythrocyte deformabilityPlasma viscosityMultiple myelomaChemistryComplete remissionHematologyVenous bloodMiddle AgedBlood Viscositymedicine.diseaseMicrocirculatory flowShear rateRed blood cellmedicine.anatomical_structure030220 oncology & carcinogenesisplasma viscosityFemaleMultiple MyelomaRheologyCardiology and Cardiovascular MedicineBiomedical engineeringClinical Hemorheology and Microcirculation
researchProduct

Plasma viscosity and insulin resistance in metabolic syndrome

2001

MaleMetabolic Syndromemedicine.medical_specialtyNutrition and Dieteticsbusiness.industryEndocrinology Diabetes and MetabolismMedicine (miscellaneous)Middle AgedBlood Viscositymedicine.diseaseEndocrinologyInsulin resistanceInternal medicineBody ConstitutionHumansMedicineFemaleInsulin ResistanceMetabolic syndromebusinessPlasma viscosityInternational Journal of Obesity
researchProduct